The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Ferroptosis involves in renal tubular cell death in diabetic nephropathy
Abstract
Ferroptosis is a novel type of programmed cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. Accumulative studies have indicated diabetic nephropathy (DN) as an inflammatory disorder, which involved immune modulation both in the occurrence and progression of the disease. In addition, DN is also considered as the major threatening complication of Diabetes mellitus (DM). However, other forms of programmed cell death, such as autophagy, apoptosis and necrosis, have been reported to be associated with DN, while there are no effective drugs to alleviate the damage of DN. In this study, we explored whether ferroptosis was involved in the progression of DN both in vivo and in vitro. We first established DN model using streptozotocin (STZ) and db/db mice. Results showed significant changes of ferroptosis associated markers, like increased expression levels of acyl-CoA synthetase long-chain family member 4 (ACSL4) and decreased expression levels of glutathione peroxidase 4 (GPX4) in DN mice. Also lipid peroxidation products and iron content were increased in DN mice. Next, in vitro, ferroptosis inducer erastin or RSL3 could induce renal tubular cell death, while iron and high ACSL4 levels sensitised ferroptosis. Finally, ACSL4 inhibitor rosiglitazone (Rosi) was used in the development of DN, which improved survival rate and kidney function, reduced lipid peroxidation product MDA and iron content. In summary, we first found ferroptosis was involved in DN and ferroptosis might be as a future direction in the treatment of DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Self-citationACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vichai, V., & Kirtikara, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.179 · Cited by 3,671
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,191
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Synchronized renal tubular cell death involves ferroptosis
Linkermann, A., Skouta, R., Himmerkus, N., Mulay, S. R., Dewitz, C., De Zen, F., Prokai, A., Zuchtriegel, G., Krombach, F., Welz, P.-S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415518111 · Cited by 1,126
Li, Y., Feng, D., Wang, Z., Zhao, Y., Sun, R., Tian, D., Liu, D., Zhang, F., Ning, S., Yao, J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0299-4 · Cited by 872
Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851
Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689
The Role of Inflammatory Cytokines in Diabetes and Its Complications
King, G. L. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080246 · Cited by 679
Shen, Z., Liu, T., Li, Y., Lau, J., Yang, Z., Fan, W., Zhou, Z., Shi, C., Ke, C., Bregadze, V. I., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06201 · Cited by 633
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI
Martin-Sanchez, D., Ruiz-Andres, O., Poveda, J., Carrasco, S., Cannata-Ortiz, P., Sanchez-Niño, M. D., Ruiz Ortega, M., Egido, J., Linkermann, A., Ortiz, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121376 · Cited by 564
Isermann, B., Vinnikov, I. A., Madhusudhan, T., Herzog, S., Kashif, M., Blautzik, J., Corat, M. A. F., Zeier, M., Blessing, E., Oh, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1667 · Cited by 385
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Gentric, G., Kieffer, Y., Mieulet, V., Goundiam, O., Bonneau, C., Nemati, F., Hurbain, I., Raposo, G., Popova, T., Stern, M.-H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.002 · Cited by 310
Expression and Characterization of Recombinant Rat Acyl-CoA Synthetases 1, 4, and 5
Kim, J.-H., Lewin, T. M., & Coleman, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010793200 · Cited by 252
Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
Lien, E. C., Lyssiotis, C. A., Juvekar, A., Hu, H., Asara, J. M., Cantley, L. C., & Toker, A. (2016) · Nature Cell Biology · doi:10.1038/ncb3341 · Cited by 249
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
The Troglitazone study group, Kumar, S., Boulton, A. J. M., Beck-Nielsen, H., Berthezene, F., Muggeo, M., Persson, B., Spinas, G. A., Donoghue, S., Lettis, S., et al. (1996) · Diabetologia · doi:10.1007/bf00418542 · Cited by 236
Mitochondrial fusion and fission in the control of apoptosis
Perfettini, J.-L., Roumier, T., & Kroemer, G. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.02.005 · Cited by 180
García‐Ropero, Á., Badimón, J. J., & Santos‐Gallego, C. G. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1551877 · Cited by 160
Mao, X., Zhou, H.-H., & Jin, W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00721 · Cited by 142
Intrarenal Purinergic Signaling in the Control of Renal Tubular Transport
Prætorius, H. A., & Leipziger, J. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135825 · Cited by 129
Facchini, F. S., & Saylor, K. L. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1204 · Cited by 92
Diabetic Kidney Disease: Act Now or Pay Later
Atkins, R. C., & Zimmet, P. (2008) · Brazilian Journal of Transplantation · doi:10.1007/s00467-009-1400-x · Cited by 90
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Lv, M., Chen, Z., Hu, G., & Li, Q. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.007 · Cited by 89
Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice
Wei, Q., Yin, X., Wang, M.-H., & Dong, Z. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00184.2005 · Cited by 69
Cao, Q., Gao, X., Lin, Y., Yue, C., Wang, Y., Quan, F., Zhang, Z., Liu, X., Lu, Y., Zhan, Y., et al. (2019) · Theranostics · doi:10.7150/thno.35015 · Cited by 58
Self-citationIron Increases Diabetes-Induced Kidney Injury and Oxidative Stress in Rats
Gao, W., Li, X., Gao, Z., & Li, H. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0021-9 · Cited by 57
Targeting of regulated necrosis in kidney disease
Martín‐Sánchez, D., Poveda, J., Fontecha‐Barriuso, M., Ruiz‐Andrés, O., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2017) · Nefrología · doi:10.1016/j.nefro.2017.04.004 · Cited by 54
Denhez, B., Rousseau, M., Dancosst, D.-A., Lizotte, F., Guay, A., Auger‐Messier, M., Côté, A. M., & Geraldes, P. (2019) · Diabetes · doi:10.2337/db18-0837 · Cited by 50
Effect of the oral iron chelator deferiprone in diabetic nephropathy rats
Zou, C., Liu, X., Liu, R., Wang, M., Sui, M., Mu, S.-H., Li, L., Ji, L., & Xie, R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12420 · Cited by 42
Inflammation and immunity in diabetic vascular complications
Nilsson, J. Å., Bengtsson, E., Fredrikson, G. N., & Björkbacka, H. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830f47cd · Cited by 36
Diabetic kidney disease: Act now or pay later
Atkins, R. C., & Zimmet, P. (2010) · Nephrology · doi:10.1111/j.1440-1797.2009.01258.x · Cited by 9
Hanif, M. O., Bali, A., & Ramphul, K. (2019) · StatPearls · Cited by 7
Cited by
Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
Ding, K., Liu, C., Li, L., Yang, M., Jiang, N., Luo, S., & Sun, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002533 · Cited by 396
Regulated cell death pathways in kidney disease
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., & Ortiz, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00694-0 · Cited by 393
Ferroptosis Enhanced Diabetic Renal Tubular Injury via HIF-1α/HO-1 Pathway in db/db Mice
Feng, X., Wang, S., Sun, Z., Dong, H., Yu, H., Huang, M., & Gao, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626390 · Cited by 321
Self-citation
Metadata
- Authors
- Wang, Y., Bi, R., Quan, F., Cao, Q., Lin, Y., Yue, C., Cui, X., Yang, H., Gao, X., & Zhang, D.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 888
- Pages
- 173574
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W3088448671
- Cited by
- 268
- References
- 35
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.